We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-14.68%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$30.2B
AUM Growth
-$16.4B
(-35%)
Cap. Flow
-$9.03B
Cap. Flow
% of AUM
-29.95%
Top 10 Holdings %
Top 10 Hldgs %
24.78%
Holding
2,286
New
90
Increased
145
Reduced
1,551
Closed
496
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$38.4M |
| 2 |
VF Corp
VFC
|
+$38.2M |
| 3 |
Sherwin-Williams
SHW
|
+$37.3M |
| 4 |
Stanley Black & Decker
SWK
|
+$35.4M |
| 5 |
A.O. Smith
AOS
|
+$35.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1B |
| 2 |
Microsoft
MSFT
|
+$833M |
| 3 |
Amazon
AMZN
|
+$495M |
| 4 |
Tesla
TSLA
|
+$313M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.16% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Consumer Staples | 11.2% |
| 4 | Healthcare | 10.36% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORGN
1676
DELISTED
Origin Materials
ORGN
| $62K | ﹤0.01% |
+398
| New | +$75.9K |
|
|
CTIC
1677
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $62K | ﹤0.01% |
+10,405
| New | +$53.3K |
|
|
DHC
1678
Diversified Healthcare Trust
DHC
$2.26B
| $60K | ﹤0.01% |
33,578
-19,254
| -36% | -$44K |
|
1679
Marathon Digital Holdings
MARA
$4.62B
| $60K | ﹤0.01% |
11,345
-6,550
| -37% | -$87.6K |
|
1680
SmartRent
SMRT
$183M
| $60K | ﹤0.01% |
+13,369
| New | +$67.5K |
|
|
AGEN
1681
Agenus
AGEN
$249M
| $59K | ﹤0.01% |
1,546
-548
| -26% | -$19.9K |
|
1682
Caribou Biosciences
CRBU
$156M
| $59K | ﹤0.01% |
10,793
-4,973
| -32% | -$38K |
|
1683
IonQ
IONQ
$12.3B
| $59K | ﹤0.01% |
+13,348
| New | +$94.5K |
|
1684
Ocular Therapeutix
OCUL
$1.86B
| $59K | ﹤0.01% |
14,633
-7,683
| -34% | -$29K |
|
|
TDAY
1685
USA Today Co
TDAY
$1.23B
| $58K | ﹤0.01% |
20,383
-10,962
| -35% | -$41.7K |
|
|
CRGE
1686
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $58K | ﹤0.01% |
+12,148
| New | +$62.7K |
|
|
FSP
1687
Franklin Street Properties
FSP
$44.8M
| $57K | ﹤0.01% |
13,757
-8,602
| -38% | -$41.2K |
|
|
ORC
1688
Orchid Island Capital
ORC
$1.31B
| $57K | ﹤0.01% |
3,998
-1,099
| -22% | -$16.3K |
|
1689
Oscar Health
OSCR
$8.5B
| $57K | ﹤0.01% |
+13,272
| New | +$84.5K |
|
1690
TETRA Technologies
TTI
$1.23B
| $57K | ﹤0.01% |
13,984
-9,028
| -39% | -$39.8K |
|
|
BTRS
1691
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $57K | ﹤0.01% |
11,268
-6,560
| -37% | -$37.7K |
|
|
BLUE
1692
DELISTED
bluebird bio
BLUE
| $56K | ﹤0.01% |
680
-316
| -32% | -$24.5K |
|
|
BBBY
1693
DELISTED
Bed Bath & Beyond Inc
BBBY
| $55K | ﹤0.01% |
11,243
-10,341
| -48% | -$120K |
|
1694
Ocugen
OCGN
$410M
| $54K | ﹤0.01% |
24,045
-10,606
| -31% | -$25.4K |
|
1695
Riot Platforms
RIOT
$8.52B
| $54K | ﹤0.01% |
13,156
-7,006
| -35% | -$65K |
|
1696
Immunovant
IMVT
$8.09B
| $53K | ﹤0.01% |
13,564
-6,090
| -31% | -$26.3K |
|
1697
Senseonics Holdings Inc
SENS
$254M
| $53K | ﹤0.01% |
2,573
-1,479
| -37% | -$38.6K |
|
|
BHIL
1698
DELISTED
Benson Hill, Inc.
BHIL
| $53K | ﹤0.01% |
+550
| New | +$64.7K |
|
1699
Seres Therapeutics
MCRB
$48.1M
| $52K | ﹤0.01% |
755
-373
| -33% | -$32.1K |
|
1700
Gevo
GEVO
$396M
| $51K | ﹤0.01% |
22,112
-15,176
| -41% | -$55.5K |
|
Similar funds
ProShare Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, ProShare Advisors held 2,286 positions worth $30.2B, down 35% from $46.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors withdrew a net $9.03B in Q2 2022, closing 496 positions and reducing 1,551 holdings. Its most notable exit was People's United Financial Inc, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in Peoples Bancorp worth $8.14M.
- ProShare Advisors's largest Q2 2022 buy was Peoples Bancorp: 305,862 shares worth $8.14M.
- ProShare Advisors added most to Pentair in Q2 2022, an estimated $38.4M increase.
- ProShare Advisors's biggest Q2 2022 reduction was Apple, cutting an estimated $1B.
- ProShare Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $163M.
- ProShare Advisors's ten largest holdings make up 25% of its $30.2B portfolio in Q2 2022.
- ProShare Advisors opened 90 new positions and closed 496 in Q2 2022.
- ProShare Advisors's portfolio value fell 35% quarter-over-quarter to $30.2B.
Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.